Appetite suppressant is first treatment to pass strict US long-term usage criteria

For the first time, a drug has been shown to help people lose weight and keep it off for several years without raising their risk of heart problems.

There is hope that lorcaserin, sold in US since 2013 under the name Belviq, could help tackle the obesity epidemic.

Continue reading…

Read More Weight-loss drug Belviq not linked to heart problems, finds study

Facebook Comments